Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
Condition(s):Type 2 Diabetes MellitusLast Updated:August 23, 2007Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes MellitusLast Updated:August 23, 2007Completed
Condition(s):Diabetes; Impaired Glucose ToleranceLast Updated:July 16, 2009Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 21, 2018Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:April 18, 2018Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:October 10, 2023Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:November 17, 2017Completed
Condition(s):Congestive Heart FailureLast Updated:July 2, 2017Completed
Condition(s):Impaired Glucose Tolerance; DiabetesLast Updated:May 24, 2012Completed
Condition(s):Insulin ResistanceLast Updated:December 5, 2016Completed
Condition(s):Bladder CancerLast Updated:July 15, 2013Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.